II 116th CONGRESS 2d Session S. 3250 IN THE SENATE OF THE UNITED STATES February 4, 2020 Mr. Cornyn (for himself and Ms. Rosen ) introduced the following bill; which was read twice and referred to the Committee on Homeland Security and Governmental Affairs A BILL To ensure U.S. Customs and Border Protection officers, agents, and other personnel have adequate synthetic opioid detection equipment, that the Department of Homeland Security has a process to update synthetic opioid detection capability, and for other purposes.

1. Short title This Act may be cited as the DHS Opioid Detection Resilience Act of 2020 . 2. Strategy to ensure detection of all opioid purity levels at ports of entry Not later than 180 days after the date of the enactment of this Act, the Commissioner of U.S. Customs and Border Protection (referred to in this section as CBP ) shall— (1) implement a strategy to ensure deployed chemical screening devices are able to identify in an operational environment narcotics at purity levels less than or equal to 10 percent, or provide directors of ports of entry with an alternate method for identifying narcotics at lower purity levels; and (2) require testing of any new chemical screening devices to understand the abilities and limitations of such devices relating to identifying narcotics at various purity levels before CBP commits to the acquisition of such devices. 3. Plan to ensure opioid detection equipment resiliency (a) In general Not later than 180 days after the date of the enactment of this Act, the Secretary of Homeland Security shall implement a plan for the long-term development of a centralized spectral database for chemical screening devices. (b) Requirements The plan required under subsection (a) shall address the following: (1) How newly identified spectra will be collected, stored, and distributed to such devices in their operational environment, including at ports of entry. (2) Identification of parties responsible for updates and maintenance of the centralized spectral database.